创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Recent Advances of Antibody Drugs in Tumor Therapy
QIN Yuting, PAN Mingzhu, ZHANG Juan
2024, 48(1): 6-19. DOI: 10.20053/j.issn1001-5094.2024.01.002
Abstract PDF
Research Progress of Small-Format Antibody Drug Conjugates and Analogs
YU Yue, CHEN Yu, MA Ningning
2024, 48(1): 20-30. DOI: 10.20053/j.issn1001-5094.2024.01.003
Abstract PDF
Clinical Progress of Antibody Drugs for Pain Treatment
WANG Yongmei, PENG Kaiting, WANG Qi, WANG Guifeng, WANG Chunhe
2024, 48(1): 31-40. DOI: 10.20053/j.issn1001-5094.2024.01.004
Abstract PDF
Research Progress of Antibody Drugs Targeting Multipass Membrane Proteins
DING Yanchao, ZENG Ziyan, ZHENG Peiyuan, HUO Yuantong, DU Juanjuan
2024, 48(1): 41-56. DOI: 10.20053/j.issn1001-5094.2024.01.005
Abstract PDF
Research Progress of Interleukin-2 Inducible Tyrosine Kinase Inhibitors
HE Sijie, ZHANG Nanxia, YANG Mengyu, TANG Weifang
2024, 48(1): 57-69. DOI: 10.20053/j.issn1001-5094.2024.01.006
Abstract PDF
Advances in Research on Half-Life of Therapeutic Antibodies
WU Yahui, LUO Longlong, ZHANG Ran
2024, 48(1): 70-附页2. DOI: 10.20053/j.issn1001-5094.2024.01.007
Abstract PDF